Animal Models of Multiple Myeloma and Their Utility in Drug Discovery-Reference-Cited by-同舟云学术

Animal Models of Multiple Myeloma and Their Utility in Drug Discovery

Published:2008-03 Issue:1 Volume:40 Page:
ISSN:1934-8282
Container-title:Current Protocols in Pharmacology
language:en
Short-container-title:Current Protocols in Pharmacology

Author:

Campbell Richard A.¹,Berenson James R.¹

Affiliation:

1. Institute for Myeloma & Bone Cancer Research West Hollywood California

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/0471141755.ph1409s40

Reference34 articles.

1. The SCID mouse as a model for multiple myeloma

2. Development of an in vivo model of human multiple myeloma bone disease

3. Development of an orthotopic SCID mouse-human tumor xenograft model displaying the multidrug-resistant phenotype

4. Efficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: a prospective, multicentre, phase II, single-arm study

5. Development of a novel spontaneous metastasis model of human osteosarcoma transplanted orthotopically into bone of athymic mice;Berlin O.;Cancer Res.,1993

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The anti-myeloma effects of the selective JAK1 inhibitor (INCB052793) alone and in combination in vitro and in vivo;Annals of Hematology;2019-01-11

2. Synergistic Antimyeloma Activity of Dendritic Cells and Pomalidomide in a Murine Myeloma Model;Frontiers in Immunology;2018-08-03

3. Lenalidomide and Programmed Death-1 Blockade Synergistically Enhances the Effects of Dendritic Cell Vaccination in a Model of Murine Myeloma;Frontiers in Immunology;2018-06-18

4. Advancements in Nanomedicine for Multiple Myeloma;Trends in Molecular Medicine;2018-06

5. Targeting Attenuated Interferon-α to Myeloma Cells with a CD38 Antibody Induces Potent Tumor Regression with Reduced Off-Target Activity;PLOS ONE;2016-09-09